Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2005
05/04/2005EP1527038A1 Process for the carbonylation of ethylenically unsaturated compouds
05/04/2005EP1472188A4 Purification of onium hydroxides by electrodialysis
05/04/2005EP1364212A4 Three hybrid assay system
05/04/2005EP0815153B1 Isocyanate compositions, method for using same, use thereof for producing coatings, and resulting coatings
05/04/2005CN1612887A Phosphino-aminophosphines
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612861A Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
05/04/2005CN1612844A Purification of onium hydroxides by electrodialysis
05/04/2005CN1611507A N-(phosphonomethyl) aminoacetate, preparation and using method thereof
05/04/2005CN1199921C Technique for cleanly recovering byprdouct methyl chloride of glyposate acid
05/04/2005CN1199696C Multipurpose packages for steroilizing products or prdoucts on be sterilised
05/03/2005US6888031 Reacting organic phosphorus halide compound with an alkali metal or with magnesium in combination with lithium, or with mixtures thereof, with or without a catalyst, and subsequent reaction with acid halides; oxidation or reaction with sulfur
05/03/2005US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents
05/03/2005US6887950 Phosphine oxide hydroxyaryl mixtures with novolac resins for co-curing epoxy resins
04/2005
04/28/2005WO2005038037A2 Methods for preparing phospholipids containing omega-3 and omega-6 moieties
04/28/2005WO2005037847A1 Tantalum amide complexes for depositing tantalum-containing films, and method of making same
04/28/2005WO2005037833A1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity
04/28/2005WO2005037779A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005WO2005037228A2 Halogen phosphonate monoesters
04/28/2005WO2005037206A2 Anti-cancer compounds and methods of use thereof
04/28/2005WO2005037205A2 Haloacetamide and azide substituted compounds and methods of use thereof
04/28/2005WO2005000994A3 Epoxy-stabilized polyphosphate compositions
04/28/2005WO2004092188A3 Analogs of lysophosphatidic acid and methods of making and using thereof
04/28/2005US20050090694 Process for the carbonylation of an ethylenically unsaturated compound and catalyst therefore
04/28/2005US20050090678 Phosphonites, use thereof as ligand in transition metal complexes and method for production of nitriles
04/28/2005US20050090677 Phosphinites
04/28/2005US20050090673 Novel diepoxide derivatives of diallyl phenolics
04/28/2005US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts
04/28/2005US20050090534 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy
04/28/2005US20050090471 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/28/2005US20050090470 alkylation of 1,3-diaminopropane or addition to diethyl vinylphosphonate, to form N-(3-aminopropyl)aminoethanephosphonic acid diethyl ester, which is condensed with a squarate compound to give drugs used as N-methyl-D-aspartic acid (NMDA) antagonists
04/28/2005US20050090469 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
04/28/2005US20050090431 Water soluble prodrugs of hindered alcohols
04/28/2005US20050089632 Producing bismuth-containing ferroelectric or superconducting films by the Atomic Layer Deposition where a silylamido ligand is used as a source material for the bismuth; e.g. tris(bis(trimethylsilyl)amido)bismuth(III)
04/28/2005US20050089573 Oral pharmaceutical formulation containing ibandronate
04/28/2005CA2542807A1 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/28/2005CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
04/27/2005EP1526138A1 Process for the preparation of polyalkoxyamines or use as initiators of radical polymerizations of polyfunctional living polymers
04/27/2005EP1526137A1 Process to prepare alkyl phenyl phosphates
04/27/2005EP1525207A2 Process for purification of zoledronic acid
04/27/2005EP1525206A1 Polyaminomethylenephos phonate derivatives
04/27/2005EP1368361B1 Derivative of phosphoric acid ester salt or phosphoric acid ester adduct or mixtures thereof, method for the production thereof and their use
04/27/2005EP0968181B1 Perfluorynated sulphone salts, and their uses as ionic conduction materials
04/27/2005CN1610688A Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
04/27/2005CN1610660A Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
04/27/2005CN1609112A Production process of N-phosphono methyl imido diacetic acid
04/27/2005CN1609111A Production process of N-phosphono methyl glycine
04/27/2005CN1198834C Water soluble produgs of hindered alcohols or phenols
04/27/2005CN1198833C Vinyl pyrrolidone cephlosporins with basic substitutent group
04/27/2005CN1198832C New amino propylphosphinic acid
04/27/2005CN1198831C Organic metal monoacylalkylphosphine compound
04/27/2005CN1198828C Weakly coordinating anions containing polyfluoroalkoxide ligands
04/26/2005US6884857 Contacting an olefin monomer or monomers under polymerization conditions in the presence of a catalyst system containing an inert catalyst support, a metal coordination complex and an alkylalumoxane
04/26/2005US6884791 Bactericides; antibiotic resistance
04/26/2005US6884401 Method for removing volatile components from a high viscosity liquid by using rotation pack bed
04/24/2005CA2482501A1 Process for preparing polyalkoxyamines useable as initiators for the free radical polymerization of living polyfunctional (co)polymers
04/21/2005WO2005035546A1 Peptide nucleic acid conjugates and uses thereof
04/21/2005WO2005035543A1 Tricyclic phosphine-phosphinites and the use thereof in catalysis
04/21/2005WO2005035542A1 Solid-state form of alendronate sodium and preparation thereof
04/21/2005WO2005034903A1 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer
04/21/2005WO2005017129B1 Phosphoramide and uses thereof
04/21/2005WO2005014525A3 Bi-aryl compound having immunosuppressive activity
04/21/2005WO2005005440A3 Novel organosilicon compounds and a method for their production
04/21/2005WO2004104199A3 Modulation of gene expression using dna-dna hybrids
04/21/2005US20050085655 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
04/21/2005US20050085555 Composition, synthesis and therapeutic applications of polyamines
04/21/2005US20050085377 Bisarylphosphines as catalyst
04/21/2005US20050084763 low melting electrolyte comprising salts where the anionic charge is delocalized, mixed with metallic salts, polar polymers and/or aprotic solvents
04/21/2005US20050084488 3-Hydroxy-4-aminomethylamido phosphorolane immunoconjugates used to elicit antibodies that catalyze the deamidation of asparagine to aspartic acid
04/21/2005US20050084451 Novel chelating agents and chelates and their use
04/21/2005CA2578473A1 Peptide nucleic acid conjugates and uses thereof
04/20/2005EP1524281A2 Isocyanate containing compositions, process for their use, process for preparing coatings, and coatings
04/20/2005EP1320534B1 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
04/20/2005CN1608074A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
04/20/2005CN1608073A A process for preparing N-acylated lysophosphatidylcholine compounds and a pharmaceutical composition for treatment of metabolic bone disease comprising said compounds
04/20/2005CN1608061A Therapeutic isoquinoline compounds
04/20/2005CN1608048A Method for the production of quaternary salt phenolate solutions and for the regeneration and recycling of quaternary salt phenolate solutions from reaction mixtures
04/20/2005CN1607204A Cyclophosphamide quaternary ammonium salt derivant and its synthesis and use
04/20/2005CN1607203A Method for synthesizing phosphonium salt by three organo-phosphines and alkyl halide hydrocarbon
04/20/2005CN1197868C Method for preparing water soluble sulphonated organophosphorous compounds
04/19/2005US6881867 Method for hydroformylation, xanthene-bridged ligands and catalyst comprising a complex of said ligands
04/19/2005US6881698 Ion liquids derived from Lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
04/19/2005CA2192226C Ruthenium complexes with a chiral, bidentate phosphine/oxazoline ligand for enantioselective transfer hydrogenation of prochiral ketones
04/14/2005WO2005033244A1 Metal complexes
04/14/2005WO2005033120A1 Method for producing carbapenem derivative
04/14/2005WO2005033117A1 Process for producing optically active dihydropyridinephosphonic ester
04/14/2005WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators
04/14/2005WO2005032494A2 Lpa receptor agonists and antagonists and methods of use
04/14/2005WO2005032492A2 Site and rate selective prodrug formulations of d609 with antioxidant and anticancer activity
04/14/2005WO2005014536A3 Podophyllotoxin derivatives
04/14/2005WO2005000858A3 Bisphosphonate complexes
04/14/2005WO2005000777A3 Process for the preparation of cinnamaldehyde compounds
04/14/2005WO2004105700A3 Compounds, methods and pharmaceutical compositions for inhibiting parp
04/14/2005WO2004094440A3 Tertiary phosphines and their methods of preparation
04/14/2005WO2004014926A8 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation
04/14/2005WO2003075902A3 Derivatives of 1, 3-cyclic propanediol phosphate and their action as cell stimulants
04/14/2005US20050080281 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
04/14/2005US20050080215 Method for preparing polyorganosiloxanes (pos) by polycondensation/redistribution of oligosiloxanes in the presence of a strong base and strong bases used
04/14/2005US20050080172 Non-xenoestrogenic stabilizers for organic materials